To be more efficient and to have single sources of the truth in their data, customers are seeking to leverage modern, standard application programmer interfaces (APIs) to integrate into their software.
Manufacturing operations face a multitude of cyber threats. The latest dangers from hackers include not only the theft of intellectual property but also malicious attacks that can cripple critical infrastructure, such as energy plants, utilities, and large-scale factories.
When the ergonomics team at General Motors decided to field test wearables to augment their plant workers’ physical abilities, they partnered with body mechanics experts who collect data in a scientific way—and talked with users.
What makes a CAM system “good,” in our opinion, is the quality of its post processor and the technical support provided by the vendor. When programming questions are answered quickly and accurately, and the system produces good code, programming is simplified and machine utilization goes up, while both setup and cycle times drop.
John Deere’s Eric Johnson discusses the company’s additive manufacturing journey—with an eye toward helping small and medium businesses get going in AM. Learn about the early days of getting one of the first AM parts, as well as unrealistic expectations of the technology and how John Deere is creating value with the technology today. Finally, Johnson provides tips on unlocking the value of AM for your business in five key applications.
Engineers at DP Technology Corp. developed highly optimized support for Willemin-Macodel within its ESPRIT CAM
Three partners contributed their diverse manufacturing and machining experience—and their last initials—to found SPR Machine in 2002.
The U.S. Department of Defense (DoD) wants the industry to secure the country’s leadership in hypersonic weaponry. The request is no small feat.
Deloitte and Wichita State University announced the launch of The Smart Factory @ Wichita,
In January, as the new coronavirus was rapidly spreading around the world, scientists at Moderna teamed up with the National Institutes of Health to pursue a potential vaccine based on an experimental genetic technology involving messenger RNA (mRNA), a molecule in every cell that helps translate DNA into biological functions.